Bio Consult ApS: Financial statements 2025
CVR: 44293277
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Bio Consult ApS (CVR 44293277) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -11,300 and a net result of DKK -11,300. Equity in the 2025 report amounted to DKK 32,500. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -11,300
- Profit/Loss
- DKK -11,300
- Equity
- DKK 32,500
- Total Assets
- DKK 32,500
- Employees
- 0
Official annual report
How creditworthy is Bio Consult ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Bio Consult ApS has published its interim report for the period September 11, 2023 – December 31, 2024.
As of July 10, 2025, Tonni Brammer Pedersen has left the board of directors of Bio Consult ApS.
As of July 10, 2025, Michael Krag Nielsen is registered as adm. dir. of Bio Consult ApS.
As of June 30, 2025, Erik Torngaard Hansen has left the board of directors of Bio Consult ApS.
As of June 30, 2025, Jan Stagsted has left the board of directors of Bio Consult ApS.
As of June 30, 2025, Jan Stagsted has stepped down as adm. dir. of Bio Consult ApS.
As of June 3, 2025, Christian Gommesen-Byrjalsen has left the board of directors of Bio Consult ApS.
About Bio Consult ApS
Bio Consult ApS is a Danish company of the type Anpartsselskab based in Nørresundby, founded in 2023. The company is registered under the industry Anden teknisk rådgivning. The company was previously named DC Proteins ApS. The management consists of Michael Krag Nielsen. The board consists of Michael Krag Nielsen (chair). The company is owned by Michael Krag Nielsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,300 and a net result of DKK -11,300. Equity in the 2025 report amounted to DKK 32,500.